EZP-23641-56152
4 vaccinations
9 coded responses
43 check-ins
9 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 060 / CT
- Registered
- 2021-04-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-15
Dose 1 — Moderna
-
2021-04-30
Registered in v-safe
- 2021-04-30
- 2021-05-06
-
2021-05-13
Dose 2 — Moderna
- 2021-05-13
-
2021-05-14
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to workFree text: Mild dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-15
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · HeadacheFree text: Mild dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-16
- 2021-05-17
- 2021-05-18
- 2021-05-19
- 2021-05-20
- 2021-05-27
- 2021-06-03
- 2021-06-10
- 2021-06-17
- 2021-06-26
- 2021-08-12
-
2021-11-11
Survey response — 6 months, dose 2MedDRA: Cough, Nasopharyngitis, Oropharyngeal pain, Sinus pain, Sinusitis, Sneezing — Feeling: Good · Be unable to work or attend schoolFree text: Suspected cold (sore throat, sneezing, coughing, no fever) followed by sinus infection (sinus pain, coughing, sneezing). Cold began 10/28, sinus infection began 11/1 as cold symptoms went away.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-16
Dose 3 — Pfizer-BioNTech
-
2021-12-19
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Good · Site: Pain, RednessFree text: Armpit painMedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Good · Site: RednessFree text: Very mild soreness in armpitMedDRA releases: 2024-11 · check-in free text available
- 2021-12-21
- 2021-12-22
- 2021-12-23
-
2021-12-30
Survey response — day 14, dose 3MedDRA: Exposure to SARS-CoV-2, Headache, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Positive COVID-19 PCR test following exposure; congestion, running nose, sore throat, headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-01-06
-
2022-01-14
Survey response — day 28, dose 3MedDRA: Brain fog, Disorientation, Disturbance in attention — Feeling: GoodFree text: Brain fogunable to concentrate, slight disorientationMedDRA releases: 2024-11 · check-in free text available
- 2022-01-21
- 2022-01-27
- 2022-03-17
- 2022-06-18
-
2022-10-21
Dose 4 — ModernaCo-administered: Flu
-
2022-10-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-10-23
Survey response — days 1–6 daily, dose 4MedDRA: Axillary pain — Feeling: Good · Site: Pain, Redness, Swelling · Headache, Joint painsFree text: Underarm painMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling, Itching · Muscle or body achesAdult check-in
-
2022-10-25
Survey response — days 1–6 daily, dose 4MedDRA: Axillary pain — Feeling: Good · Site: Pain, Redness, ItchingFree text: Underarm painMedDRA releases: 2024-11 · check-in free text available
-
2022-10-26
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
- 2022-10-27
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-11-18
- 2022-11-25
- 2022-12-02
- 2023-01-20
- 2023-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-15 | Moderna | |
| 2 | 2021-05-13 | Moderna | |
| 3 | 2021-12-16 | Pfizer-BioNTech | No |
| 4 | 2022-10-21 | Moderna | Flu |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Mild dizziness
Systemic reaction (other): Mild dizziness
Release 10 — 6 months, dose 2
Symptoms: Suspected cold (sore throat, sneezing, coughing, no fever) followed by sinus infection (sinus pain, coughing, sneezing). Cold began 10/28, sinus infection began 11/1 as cold symptoms went away.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Armpit pain
Systemic reaction (other): Very mild soreness in armpit
Release 10 — day 14, dose 3
Symptoms: Positive COVID-19 PCR test following exposure; congestion, running nose, sore throat, headache
Release 10 — day 28, dose 3
Symptoms: Brain fogunable to concentrate, slight disorientation
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Underarm pain
Systemic reaction (other): Underarm pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Disorientation | · | · | ✓ |
| SD | Disturbance in attention | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinus pain | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release